Business Context and Reporting Period
Company: IRADIMED CORP
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2019
Event Date: March 26, 2019
The filing reports the entry into a material definitive agreement. Specifically, the Company amended an existing Supply Agreement with Fukoku Co., Ltd., originally dated January 26, 2014.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Agreement Extension: The term of the Supply Agreement with Fukoku Co., Ltd. was extended through February 25, 2024.
- Documentation: The full text of the Amendment is not included in this report but will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the first quarter of 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document strictly reports the execution of the contract amendment.
Investor Verification Checklist
- Verify the specific terms and conditions of the amended Supply Agreement by reviewing the exhibit in the upcoming Form 10-Q for Q1 2019.
- Confirm the strategic importance of Fukoku Co., Ltd. to the Company's supply chain and revenue stability.
- Monitor the Company's subsequent 10-Q filing for any financial impact resulting from the extended agreement term.